Adverse Events From Cosmetics Increase, Prompting Calls for More Regulation

Adverse Events From Cosmetics Increase, Prompting Calls for More Regulation

Nearly 1,600 reports of adverse events related to cosmetics and personal care products were reported to the FDA last year. Since cosmetics manufacturers are not required to disclose adverse events to the FDA, and the industry doesn’t have the kind of regulations for approval that drugs do, researchers say some kind of premarket approval for certain products may be necessary.

For the first time, the FDA last year made available data from its Center for Food Safety and Applied Nutrition’s Adverse Event Reporting System. The database contains adverse events — reported mostly by consumers and healthcare professionals — related to cosmetics, as well as dietary supplements and foods. The first reports to the database came in 2004.

An analysis of the database conducted by researchers found that there were 5,144 adverse events related to cosmetics and personal care products between 2004 and 2016, according to a research letter published in JAMA. Between 2015 and 2016, there was a significant increase in reports, especially with hair care products. Overall, hair care, skin care and tattoos accounted for the most events.

Adverse events ranged from nonserious injury to some reports of disability, congenital defects and even death after using certain products.

Because the adverse events are self-reported, the true number is likely much, much higher. For example, in 2014, the FDA began to look at hair conditioners from WEN by Chaz Dean following more than 100 reports of people’s hair falling out after using the product. When the agency contacted the company, however, they found it had received more than 21,000 complaints of hair loss and scalp problems.

“The first step to improve cosmetic safety is broader reporting, especially from manufacturers,” the authors write. “For products blurring the line between drug and cosmetic (cosmeceuticals), a form of premarket approval should be considered.”

They also call for the passage of the Personal Care Products Safety Act, which was introduced by Sen. Dianne Feinstein (D-Calif.). The bill would give the FDA authority to recall unsafe cosmetics and mandate that manufacturers report adverse events.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement